Dublin, May 29, 2024 (GLOBE NEWSWIRE) -- The "Meningococcal Vaccines Market Report 2024-2034" report has been added to ResearchAndMarkets.com's offering.
Meningococcal Vaccines Market will surpass US$3,100.0 million in 2024 with strong revenue growth through to 2034
Introduction of vaccine requires immense amount of research and development. Key factors that impact R&D include lack of infrastructure, limited funding opportunities, barriers to obtaining raw material, operational insufficiencies. Furthermore, R&D costs can be manageable for large dominant players while small players face various. challenges.
Also, regulatory processes are complex and require lot of documentation and follow-up that further adds to time consuming process for vaccine research. Hence, there is a need to streamline R&D process for enhancing research.
Key Questions Answered
- How is the Meningococcal Vaccines market evolving?
- What is driving and restraining the Meningococcal Vaccines market?
- How will each Meningococcal Vaccines submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?
- How will the market shares for each Meningococcal Vaccines submarket develop from 2024 to 2034?
- What will be the main driver for the overall market from 2024 to 2034?
- Will leading Meningococcal Vaccines markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
- How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?
- Who are the leading players and what are their prospects over the forecast period?
- What are the Meningococcal Vaccines projects for these leading companies?
- How will the industry evolve during the period between 2024 and 2034? What are the implications of Meningococcal
- Vaccines projects taking place now and over the next 10 years?
- Is there a greater need for product commercialisation to further scale the Meningococcal Vaccines market?
- Where is the Meningococcal Vaccines market heading and how can you ensure you are at the forefront of the market?
- What are the best investment options for new product and service lines?
- What are the key prospects for moving companies into a new growth path and C-suite?
Companies Featured
- BIO-MED
- GSK plc
- Hualan Biological Bacterin Co., Ltd.
- Incepta Pharmaceuticals Ltd.
- JN International
- Pfizer Inc.
- Sanofi
- Serum Institute of India Pvt. Ltd.
- Walvax Biotechnology Co., Ltd.
- Biovac
- EuBiologics
- Novartis
- National Institute for Health and Care Excellence (NICE) [UK]
- National Institute of Allergy and Infectious. Diseases (NIAID) [U.S.]
- National Institutes of Health [U.S.]
- European Medicines Agency (EMA)
- European Pharmaceutical Market Research Association (EPhMRA)
- Food and Drug Administration (FDA) [U.S.]
- Health Canada
- National Development and Reform Commission (NDRC) [China]
- National Health Services (NHS) [UK]
- National Pharmaceutical Pricing Authority (NPPA) [China]
- Pan American Health Organization (PAHO)
- Pharmaceuticals and Medical Devices Agency (PMDA) [Japan]
- UK Medicines and Healthcare Products Regulatory Agency (MHRA)
- World Health Organization (WHO)
Segments Covered in the Report
Type
- Polysaccharide Vaccines
- Conjugate Vaccines
- Combination Vaccines
- Men B Vaccines
Serogroups
- A, B, C, Y, W-135 Vaccines
- Serogroup B Vaccines
Brands
- Menactra
- Menveo
- Nimenrix
- Bexsero
- Trumenba
Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
MEA
- GCC
- South Africa
- Rest of MEA
For more information about this report visit https://www.researchandmarkets.com/r/6mvph8
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
